Genetic Variants of CYP19 (Aromatase) and Breast Cancer Risk

Oncogene - United Kingdom
doi 10.1038/sj.onc.1203425
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy With Aromatase Inhibitors

Breast Diseases
OncologySurgery
2010English

Genetic Variants in the MRPS30 Region and Postmenopausal Breast Cancer Risk

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2012English

Breast Cancer Risk Assessment Using Genetic Variants and Risk Factors in a Singapore Chinese Population

Breast Cancer Research
Cancer ResearchOncology
2014English

Genetic Variants Associated With Breast-Cancer Risk: Comprehensive Research Synopsis, Meta-Analysis, and Epidemiological Evidence

The Lancet Oncology
Oncology
2011English

Frequency of 14 Genetic Variants Associated With Breast Cancer Risk and Treatment in a Colombian Population

Revista Colombiana de Ciencias Químico-Farmacéuticas
2018English

Genetic Variants and Risk of Lung Cancer in Never Smokers

Thorax
PulmonaryRespiratory Medicine
2010English

Correction: A Meta-Analysis of the Association Between ESR1 Genetic Variants and the Risk of Breast Cancer

PLoS ONE
Multidisciplinary
2018English

Association of FGFR2 and PI3KCA Genetic Variants With the Risk of Breast Cancer in a Chinese Population

Cancer Management and Research
Oncology
2018English

Common Obesity-Related Genetic Variants and Papillary Thyroid Cancer Risk

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy